New Import Payment Flow: What Has Changed and How It Impacts the Medical Devices Sector

New Import Payment Flow: What Has Changed and How It Impacts the Medical Devices Sector

ANVISA presents changes to the import payment flow in the March webinar.

ANVISA Webinar Presents Changes in the Import Process

On March 17, ANVISA held a webinar to clarify the new payment flow of the health product import process. The main novelty is the integration of the ANVISA Fee into the Centralized Foreign Trade Payment (PCCE) module of the Single Foreign Trade Portal (Siscomex). The measure aims to simplify and speed up the regulatory procedure for companies operating in the sector.

Impacts of Payment Integration to Siscomex

The implementation of the new flow represents a significant evolution in the bureaucracy associated with the importation of medical devices and other products regulated by ANVISA. Among the main impacts, the following stand out:

  • Greater Agility: The unification of payment reduces the time needed for the release of products, favoring logistical predictability.
  • Simplification of the Process: Foreign and domestic companies now have a more organized and centralized flow to make payments of regulatory fees.
  • Transparency and Control: The system allows for more accurate monitoring of the steps in the process, ensuring greater security and compliance.

QR Group: How Can We Support Your Company?

As a specialist in health product regulation in Brazil, QR Group is prepared to guide international manufacturers and national distributors in adapting to the new payment model. Our team offers complete consulting for:

  • Understanding the new regulatory flow.
  • Adaptation of internal processes to the new ANVISA system.
  • Support in documentation and petitioning with regulatory authorities.

Contact QR Group

If your company operates in the medical device sector and needs to ensure compliance with the new ANVISA guidelines, contact QR Group. Our team of experts is ready to offer fast and efficient support.

Source: ANVISA